How GLP-1 Medications Are Changing Anesthesia Practice
Episode 498 of the Beyond The Mask: Innovation & Opportunities For CRNAs podcast, hosted by Beyond The Mask Podcast, titled "How GLP-1 Medications Are Changing Anesthesia Practice" was published on April 2, 2026 and runs 25 minutes.
April 2, 2026 ·25m · Beyond The Mask: Innovation & Opportunities For CRNAs
Summary
GLP-1 medications like Ozempic and Wegovy have exploded in popularity for diabetes treatment and weight loss, but their rapid rise is creating new considerations for anesthesia providers. As more patients arrive for procedures while taking these medications, CRNAs and anesthesia teams must navigate evolving guidelines, potential aspiration risks, and uncertainty about perioperative management. In this episode, Amy Reed, Ph.D, CRNA returns to discuss the latest research and recommendations surrounding GLP-1 receptor agonists in anesthesia practice. Here’s some of what you’ll hear in this episode: 💊 GLP-1 medications aren’t new but their popularity is ⚠️ Aspiration risk is still the primary anesthesia concern 📋 Guidelines are evolving and sometimes conflicting 🔍 Point-of-care gastric ultrasound is gaining traction 📊 More research is still needed Visit us online: https://beyondthemaskpodcast.com/ The 1099 CRNA Institute: https://aana.com/1099 Get the CE Certificate here (and directly submit to the NBCRNA): https://beyondthemaskpodcast.com/wp-content/uploads/2020/04/Beyond-the-Mask-CE-Cert-FILLABLE.pdf Help us grow by leaving a review: https://podcasts.apple.com/us/podcast/beyond-the-mask-innovation-opportunities-for-crnas/id1440309246 Now you can watch the show on YouTube! Check it out here: https://www.youtube.com/channel/UCknrmkRxiwtYk7LUjSV6wmw?sub_confirmation=1
Episode Description
GLP-1 medications like Ozempic and Wegovy have exploded in popularity for diabetes treatment and weight loss, but their rapid rise is creating new considerations for anesthesia providers. As more patients arrive for procedures while taking these medications, CRNAs and anesthesia teams must navigate evolving guidelines, potential aspiration risks, and uncertainty about perioperative management.
In this episode, Amy Reed, Ph.D, CRNA returns to discuss the latest research and recommendations surrounding GLP-1 receptor agonists in anesthesia practice.
Hereโs some of what youโll hear in this episode:
๐ GLP-1 medications arenโt new but their popularity is
โ ๏ธ Aspiration risk is still the primary anesthesia concern
๐ Guidelines are evolving and sometimes conflicting
๐ Point-of-care gastric ultrasound is gaining traction
๐ More research is still needed
ย
Visit us online: https://beyondthemaskpodcast.com/
The 1099 CRNA Institute: https://aana.com/1099
Get the CE Certificate here (and directly submit to the NBCRNA): https://beyondthemaskpodcast.com/wp-content/uploads/2020/04/Beyond-the-Mask-CE-Cert-FILLABLE.pdf
Help us grow by leaving a review: https://podcasts.apple.com/us/podcast/beyond-the-mask-innovation-opportunities-for-crnas/id1440309246
Now you can watch the show on YouTube! Check it out here: https://www.youtube.com/channel/UCknrmkRxiwtYk7LUjSV6wmw?sub_confirmation=1
Similar Episodes
Apr 10, 2026 ·19m
Apr 3, 2026 ·10m
Apr 3, 2026 ·24m
Mar 27, 2026 ·19m